Insulin-injection-site reactions associated with type I latex allergy [7]

New England Journal of Medicine

Volumn 348, Issue 3, 2003, Pages 265-266

  Roest, M A B ^a   Shaw, S ^a   Orton, D I ^a  

^a AMERSHAM HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN INSULIN; HYPURIN BOVINE LENTE; INSULIN; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; LATEX;

ALLERGY; CLINICAL FEATURE; HUMAN; LETTER; PRICK TEST; PRIORITY JOURNAL; URTICARIA;

ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; INSULIN; LATEX HYPERSENSITIVITY; URTICARIA;

EID: 0037448365     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200301163480320     Document Type: Letter

References (4)

1. Hoffman RP. Latex hypersensitivity in a child with diabetes. Arch Pediatr Adolesc Med 2000;154:281-2.
2. Towse A, O'Brien M, Twarog FJ, Braimon J, Moses AC. Local reaction secondary to insulin injection: a potential role for latex antigens in insulin vials and syringes. Diabetes Care 1995;18:1195-7.
3. Danne T, Niggemann B, Weber B, Wahn U. Prevalence of latex-specific IgE antibodies in atopic and nonatopic children with type I diabetes. Diabetes Care 1997;20:476-8.
4. Primeau M-N, Adkinson NF Jr, Hamilton RG. Natural rubber pharmaceutical vial closures release latex allergens that produce skin reactions. J Allergy Clin Immunol 2001;107:958-62.